A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor

International Journal of Cancer

Volumn 65, Issue 4, 1996, Pages 538-546

  Schmidt, Mathias ^a,b   Hynes, Nancy E ^c   Groner, Bernd ^a   Wels, Winfried ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY TOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOTOXIN; PSEUDOMONAS EXOTOXIN; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CELL GROWTH; CELL KILLING; CONTROLLED STUDY; EPIDERMOID TUMOR; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIBODIES, BISPECIFIC; BACTERIAL TOXINS; BASE SEQUENCE; EXOTOXINS; FEMALE; HUMANS; IMMUNOTOXINS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; VIRULENCE FACTORS;

EID: 0029978089     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960208)65:4<538::AID-IJC24>3.0.CO;2-4     Document Type: Article

References (22)

1. CHAUDHARY, V.K., FITZGERALD, D.J., ADHYA, S. and PASTAS, I., Activity of a recombinant fusion protein between transforming growth factor type ct and Pseudomonas toxin. Proc. not. Acad. Sci (Wash.), 84, 4538-4542 (1987).
2. FAS, Z., LU, Y., WU, X. and MENDELSOHN, J., Antibody-induced epidermal growth factor dimenzation mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells. J. biol Chem . 269, 27595-27602 (1994).
3. FAN, Z., MENDELSOHN, J., MASUI, H. and KUMAR, R., Regulation of epidermal growth factor receptor in NIH3T3/HER14 cells by antireceptor monoclonal antibodies. J. biol Chem., 268, 21073-21079 (1993).
4. GRAUS-PORTA, D., BEERLI, R.R. and HYNES, N.E., Single-chain antibody-mediated intracellular retention of ErbB-2 impairs neu differentiation factor and epidermal growth factor signaling. Mol. cell. Biol., 15, 1182-1191 (1995).
5. GLLLICK, W.J., Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Brit. med. Bull., 47, 87-98 (1991).
6. HARWERTH, I.M., WELS, W., MARTE, B.M. and HYNES, N.E., Monoclonal antibodies against the extracellular domain of the erbB-2 receptor function as partial ligand agonists. J. biol. Chem., 267, 15160-15167 (1992).
7. HARWERTH, I.M., WELS, W., SCHLEGEL, J., MULLER, M. and HYNES, N.E., Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth. Brit. J. Cancer. 68, 1140-1145 (1993).
8. HYNES, N.E., Amplification and over-expression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Sem. Cancer Biol., 4, 19-26 (1993).
9. JESCHKE, M., WELS, W., DENGLER, W., IMBER, R., STÖCKLIN, E. and GROXER, B., Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins. Int. J. Cancer, 60, 730-739 (1995).
10. KAWAMOTO, T., SATO. J.D., LE, A., POLIKOFF, J., SATO, G.H. and MENDELSOHN, J., Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc. nat. Acad. Sci. (Wash.), 80, 1337-1341 (1983).
11. c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292 (1989).
12. KORNILOVA, E.S., TAVERNA, D., HOECK, W. and HYNES, N.E., Surface expression of erbB-2 protein is post-transcriptionally regulated in mammary epithelial cells by epidermal growth factor and by the culture density. Oncogene, 7, 511-519 (1992).
13. KREITMAN, R.J., SIEGALL, C.B., CHAUDHARY, V.K., FITZGERALD, D.J. and PASTAN, I., Properties of chimeric toxins with two recognition domains: interleukin 6 and transforming growth factor α at different locations in Pseudomonas exotoxin. Bioconj. Chem., 3, 63-68 (1992).
14. PELES, E. and YARDEN, Y., Neu and its ligands: from an oncogene to neural factors. Bioessays, 15, 815-824 (1993).
15. erbB4. Nature (Lond), 366, 473-475 (1993).
16. 389EGF. epidermal growth factor (EGF) receptor-targeted fusion toxins. J. biol. Chem. 266, 21118-21124 (1991).
17. SIEGALL, C.B., CHAUDHARY, V.K., FITZGERALD, D.J. and PASTAN, L. Functional analysis of domains II, Ib and III of Pseudomonas exotoxin J. biol. Chem., 264, 14256-14261 (1989).
18. SLIWKOWSKI, M.X., SCHAEFER, G., AKITA, R.W., LOFGREN, J.A., FITZPATRICK, V.D., NUIJENS, A., FENDLY, B.M., CERIONE, R.A., VASDLEN, R.L. and CARRAWAY, K.L., III. Coexpression of erbB2 and erbB3 proteins reconstitutes a high-affinity receptor for heregulin. J. biol. Chem., 269, 14661-14665 (1994).
19. SOLTOFF, S.P., CARRAWAY, K.L., III, PRIGENT, S.A., GULLICK, W.G. and CANTLEY, L.C., ErbB3 is involved in activation of pnosphatidylinositol 3-kinase by epidermal growth factor. Mol. cell Biol., 14, 3550-3558 (1994).
20. neu protein and the EGF receptor modulates EGF receptor function. Cell, 61, 1339-1347 (1990).
21. crbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins. Int. J. Cancer, 60, 137-144 (1995).
22. WELS, W., HARWERTH, I.M., MUELLER, M., GRONER, B. and HYNES, N.E., Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res., 52: 6310-6317 (1992).